<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We performed <z:hpo ids='HP_0001417'>X-linked</z:hpo> restriction fragment length polymorphism (RFLP)-methylation analysis to study the clonality of hematopoiesis in five patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), who had responded to chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Two patients had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e>, two had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with an excess of blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>), and one had <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> with trilineage <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-TMDS) </plain></SENT>
<SENT sid="2" pm="."><plain>Following the administration of low-dose <z:chebi fb="0" ids="28680">cytarabine</z:chebi> therapy or of conventional intensive chemotherapy, we observed a reversion to polyclonal hematopoiesis in three patients who achieved a complete remission (CR) </plain></SENT>
<SENT sid="3" pm="."><plain>Polyclonal hematopoiesis persisted in one patient in CR, and monoclonal hematopoiesis persisted in another patient of minor response </plain></SENT>
<SENT sid="4" pm="."><plain>These results indicate that polyclonal hematopoiesis can be restored in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients who achieved CR </plain></SENT>
<SENT sid="5" pm="."><plain>We are encouraged, therefore, to administer intensive consolidation chemotherapy to prolong the duration of remission </plain></SENT>
</text></document>